Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$8.02 USD
+0.08 (1.01%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $8.03 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.10 | -6.46% |
Earnings Summary
For their last quarter, Theravance Biopharma (TBPH) reported earnings of -$0.13 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 44.44%. Look out for TBPH's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year decrease of 900%.
Earnings History
Price & Consensus
Zacks News for TBPH
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
TBPH: What are Zacks experts saying now?
Zacks Private Portfolio Services